← FDA Drug Approvals (Drugs@FDA)

ZUPLENZ

NDA · New Drug Application · Sponsor: AQUESTIVE · Approved 2010-07-02

Drug application

FDA Application #

NDA022524

Application type

New Drug Application

Brand name

ZUPLENZ

Generic name

Ondansetron

Active ingredients

ONDANSETRON

Dosage form

FILM

Route

ORAL

Marketing status

Discontinued

Sponsor

AQUESTIVE

First approval

2010-07-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown